⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5077203 | 0.74 | — | — | |
| SCHEMBL13854612 | 0.74 | — | — | |
| SCHEMBL5071885 | 0.74 | — | — | |
| SCHEMBL2570805 | 0.74 | — | — | |
| SCHEMBL3045535 | 0.70 | — | — | |
| SCHEMBL9577551 | 0.70 | — | — | |
| SCHEMBL26501754 | 0.70 | — | — | |
| SCHEMBL23133186 | 0.67 | — | — | |
| SCHEMBL16473251 | 0.67 | — | — | |
| SCHEMBL11427104 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023225320-A1 | EPHA2 BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | NOVARTIS AG (CH) | 2023-11-23 | — | — | WO | disclosed |
| WO-2023225336-A1 | MET BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | NOVARTIS AG (CH) | 2023-11-23 | — | — | WO | disclosed |
| EP-3743430-B1 | AMINOPYRROLOTRIAZINES AS KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2022115477-A1 | BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | NOVARTIS AG (CH) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022115451-A1 | MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | NOVARTIS AG (CH) | 2022-06-02 | — | — | WO | disclosed |
| WO-2021100029-A2 | PRODRUGS OF FULVESTRANT | KASHIV BIOSCIENCES, LLC (US) | 2021-05-27 | — | — | WO | disclosed |
| WO-2020236825-A2 | MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | NOVARTIS AG (CH) | 2020-11-26 | — | — | WO | disclosed |
| WO-2020236841-A2 | ANTIBODY DRUG CONJUGATES HAVING LINKERS COMPRISING HYDROPHILIC GROUPS | NOVARTIS AG (CH) | 2020-11-26 | — | — | WO | disclosed |
| WO-2020236817-A2 | MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | NOVARTIS AG (CH) | 2020-11-26 | — | — | WO | disclosed |
| WO-2019184919-A1 | ADAMANTANE-CONTAINING COMPOUND AND USE THEREOF IN TREATING CANCER | 成都海创药业有限公司 | 2019-10-03 | — | — | WO | disclosed |
| US-20150307430-A1 | HYDROFORMYLATION PROCESS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2928855-A1 | HYDROFORMYLATION PROCESS | Dow Technology Investments LLC (US) | 2015-10-14 | — | — | EP | disclosed |
| US-20140342363-A1 | Sample Preparation | INTELLIGENT BIO-SYSTEMS, INC. (US) | 2014-11-20 | — | — | US | disclosed |
| US-8883999-B2 | Methods and solutions for inhibiting undesired cleaving of labels | Intelligent Bio Systems, Inc. (US) | 2014-11-11 | — | — | US | disclosed |
| WO-2014088816-A1 | HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2014-06-12 | — | — | WO | disclosed |
| US-8177994-B2 | Electrolytic solution for aluminum electrolytic capacitors, and aluminum electrolytic capacitor using the same | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-7943751-B2 | Ladder copolymers | NEW YORK UNIVERSITY (US) | 2011-05-17 | — | — | US | disclosed |
| US-20090256105-A1 | ELECTROLYTIC SOLUTION FOR ALUMINUM ELECTROLYTIC CAPACITORS, AND ALUMINUM ELECTROLYTIC CAPACITOR USING THE SAME | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-10-15 | — | — | US | disclosed |
| EP-0115613-B1 | DNA SEQUENCES, THEIR PREPARATION, PLASMIDS CONTAINING THESE SEQUENCES AND THEIR USE IN THE SYNTHESIS OF EUKARYOTIC GENE PRODUCTS IN PROKARYOTES | BOEHRINGER INGELHEIM INTERNATIONAL GmbH (DE) | 1991-03-27 | — | — | EP | disclosed |
| US-4469863-A | ANTITUMOR AGENTS, VIRICIDES | GENTA INCORPORATED | 1984-09-04 | — | — | US | disclosed |